Market Overview:
The global viral molecular diagnostics market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of viral diseases, growing demand for early diagnosis and treatment, and technological advancements in molecular diagnostics. Based on type, the global viral molecular diagnostics market is segmented into hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human papillomavirus (HPV). HCV is expected to be the fastest-growing segment during the forecast period. This growth can be attributed to rising incidence of HCV infections across the globe and increasing demand for early diagnosis and treatment of HCV infections. Based on application, hospitals are expected to account for the largest share of the global viral molecular diagnostics market in 2018. This large share can be attributed to growing awareness about available diagnostic tests among healthcare professionals and patients, rising prevalence of infectious diseases, and increasing number of hospital admissions owing to chronic diseases such as cancer or diabetes mellitus.
Product Definition:
A viral molecular diagnostic is a laboratory technique used to detect the presence or absence of viruses in a sample. Viral molecular diagnostics can be used to diagnose infections, monitor the effectiveness of treatments, and screen for potential outbreaks. The importance of viral molecular diagnostics lies in its ability to rapidly identify viruses and help guide the appropriate treatment decisions.
Hepatitis B Virus (HBV):
Hepatitis B Virus (HBV) is a contagious liver virus. It attacks the liver and causes inflammation & scarring of the organ. The infection can be transmitted through blood and other body fluids of an infected person. Most people with HBV do not have symptoms, while some may experience mild ones such as fatigue, nausea, loss of appetite, diarrhea or vomiting.
Hepatitis C Virus (HCV):
Hepatitis C virus (HCV) is a member of the Hepatitis family. It is an RNA-based virus and its infection leads to inflammation of liver tissue. The disease can be acute or chronic as per the degree of immune response by the patient.
Application Insights:
The hospitals segment dominated the global viral molecular diagnostic market in 2017. This can be attributed to factors such as presence of a large number of laboratories within hospitals and rising prevalence of infectious diseases. According to the U.S. Department of Health & Human Services, around 60 million individuals are living with HIV worldwide, out of which only 10% are receiving antiretroviral therapy (ART). Therefore, demand for rapid molecular diagnostic tests is expected to grow at a significant pace over the forecast period owing to increasing incidence rates for various viral infections across the world coupled with an increase in R&D investments by various companies operating in this sector such as Merck Millipore Corporation and Thermo Fisher Scientific Inc., among others.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of laboratories and diagnostic testing centers, favorable reimbursement policies, and increasing awareness about early diagnosis. The U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure; rising prevalence of chronic diseases; increase in government initiatives for mass testing programs; and growing demand for cost-effective diagnostic procedures that require minimal time & effort from patients.
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing at a rapid pace. This is primarily attributed to the changing lifestyles and environmental conditions. This, in turn, is fueling the demand for molecular diagnostics for the detection and diagnosis of various infections.
- Growing awareness about viral molecular diagnostics: There is a growing awareness among healthcare professionals and patients about the benefits of using viral molecular diagnostics over traditional methods for detecting viruses. This is helping to drive the growth of this market.
- Technological advancements in viral molecular diagnostics: The technological advancements in viral molecular diagnostics are helping to improve their accuracy and speed while reducing costs simultaneously. This is aiding in driving the growth of this market significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Viral Molecular Diagnostics Market Research Report
By Type
Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)
By Application
Hospitals, Academics Institutions, Laboratories, Others
By Companies
Abbott Laboraories, Bio-Rad Laboratories, Becton, Dickinson, Roche, Gen-Probe, Qiagen, Olympus, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Viral Molecular Diagnostics Market Report Segments:
The global Viral Molecular Diagnostics market is segmented on the basis of:
Types
Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Academics Institutions, Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboraories
- Bio-Rad Laboratories
- Becton, Dickinson
- Roche
- Gen-Probe
- Qiagen
- Olympus
- Thermo Fisher Scientific
Highlights of The Viral Molecular Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Human Immunodeficiency Virus (HIV)
- Human Papillomavirus (HPV)
- By Application:
- Hospitals
- Academics Institutions
- Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Viral Molecular Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Viral molecular diagnostics is a field of diagnostic medicine that uses viral proteins to identify and diagnose viruses. Viral proteins can be extracted from samples using specific techniques, and then analyzed using a variety of methods to determine the virus type or species. This information can then be used to guide treatment options for patients with suspected infections.
Some of the major players in the viral molecular diagnostics market are Abbott Laboraories, Bio-Rad Laboratories, Becton, Dickinson, Roche, Gen-Probe, Qiagen, Olympus, Thermo Fisher Scientific.
The viral molecular diagnostics market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Viral Molecular Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Viral Molecular Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Viral Molecular Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Viral Molecular Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Viral Molecular Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Viral Molecular Diagnostics Market Size and Y-o-Y Growth
4.5.2 Viral Molecular Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Viral Molecular Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Viral Molecular Diagnostics Market Size Forecast by Type
5.2.1 Hepatitis B Virus (HBV)
5.2.2 Hepatitis C Virus (HCV)
5.2.3 Human Immunodeficiency Virus (HIV)
5.2.4 Human Papillomavirus (HPV)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Viral Molecular Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Viral Molecular Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Academics Institutions
6.2.3 Laboratories
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Viral Molecular Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Viral Molecular Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Viral Molecular Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Viral Molecular Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Viral Molecular Diagnostics Market Size Forecast by Type
9.6.1 Hepatitis B Virus (HBV)
9.6.2 Hepatitis C Virus (HCV)
9.6.3 Human Immunodeficiency Virus (HIV)
9.6.4 Human Papillomavirus (HPV)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Viral Molecular Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Academics Institutions
9.10.3 Laboratories
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Viral Molecular Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Viral Molecular Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Viral Molecular Diagnostics Market Size Forecast by Type
10.6.1 Hepatitis B Virus (HBV)
10.6.2 Hepatitis C Virus (HCV)
10.6.3 Human Immunodeficiency Virus (HIV)
10.6.4 Human Papillomavirus (HPV)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Viral Molecular Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Academics Institutions
10.10.3 Laboratories
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Viral Molecular Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Viral Molecular Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Viral Molecular Diagnostics Market Size Forecast by Type
11.6.1 Hepatitis B Virus (HBV)
11.6.2 Hepatitis C Virus (HCV)
11.6.3 Human Immunodeficiency Virus (HIV)
11.6.4 Human Papillomavirus (HPV)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Viral Molecular Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Academics Institutions
11.10.3 Laboratories
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Viral Molecular Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Viral Molecular Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Viral Molecular Diagnostics Market Size Forecast by Type
12.6.1 Hepatitis B Virus (HBV)
12.6.2 Hepatitis C Virus (HCV)
12.6.3 Human Immunodeficiency Virus (HIV)
12.6.4 Human Papillomavirus (HPV)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Viral Molecular Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Academics Institutions
12.10.3 Laboratories
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Viral Molecular Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Viral Molecular Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Viral Molecular Diagnostics Market Size Forecast by Type
13.6.1 Hepatitis B Virus (HBV)
13.6.2 Hepatitis C Virus (HCV)
13.6.3 Human Immunodeficiency Virus (HIV)
13.6.4 Human Papillomavirus (HPV)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Viral Molecular Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Academics Institutions
13.10.3 Laboratories
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Viral Molecular Diagnostics Market: Competitive Dashboard
14.2 Global Viral Molecular Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboraories
14.3.2 Bio-Rad Laboratories
14.3.3 Becton, Dickinson
14.3.4 Roche
14.3.5 Gen-Probe
14.3.6 Qiagen
14.3.7 Olympus
14.3.8 Thermo Fisher Scientific
